What is it with this administration — a general envy and resentment of success (“You didn't build that!”) or just a general incompetence at anything to do with basic economics? Like the old and bitter truth that the surest way to make something scarcer is to tax it.
The administration's latest victim is the American medical device industry — the people who make everything from body-scanning machines to catheters to glucose meters, anything regulated by the Food and Drug Administration. Like pacemakers, defibrillators, artificial joints, heart stents, chemotherapy delivery systems. … If a medical device helps folks, the tax on every sale just went up 2.3 percent.
Yes, this is another sales tax, not an income tax. Which means it'll actually take a much higher percentage of these companies' incomes. Which in turn means there'll be fewer new medical devices (it takes profits to finance research and development) and more pink slips. And soon enough, less revenue for the government itself as the industry shrinks, and taxable income with it.
Obamacare turns out to be the gift that just keeps on taking. And every new exaction always comes as a surprise to the unwary. Taxes that were just going to hit the very rich — those envied and resented 1 percent — have a way of hitting those who need help the most.
This time the victims are those companies — and their employees — that make medical devices. The new, higher tax on sales of their lifesaving products will mean more layoffs, more companies moving offshore, and more markets lost to foreign competitors. And this country's technological edge in producing new and innovative medical devices will be whittled away as their manufacturers have to cut back on their research and development.
If there's a way to discourage invention and innovation, drive up costs, eliminate jobs, help foreign competitors at the expense of American businesses, and generally make this weak economic recovery even weaker, you can bet this president will find it.